SCHEMBL2995440

SCHEMBL2995440

CCCCOc1ccc(CCl)cc1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.56
LTA4H P09960 3/20 0.53
NR5A1 Q13285 1/20 0.52
CYP2D6 P10635 2/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
KDM4E B2RXH2 1/20 0.51
CYP1A2 P05177 1/20 0.51
PDE4A P27815 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HIF1A Q16665 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
ALDH1A1 P00352 1/20 0.50
TP53 P04637 1/20 0.50
HPGD P15428 1/20 0.50
CYP3A4 P08684 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6018241 0.96 NR5A1 (0.58) TSHRLTA4HNR5A1NPC1RAB9A
SCHEMBL3051075 0.94 NR5A1 (0.61) TSHRLTA4HNR5A1NPC1RAB9A
SCHEMBL11081319 0.94 NR5A1 (0.61) TSHRLTA4HNR5A1NPC1RAB9A
SCHEMBL3051340 0.94 NR5A1 (0.61) TSHRLTA4HNR5A1NPC1RAB9A
SCHEMBL3041460 0.94 NR5A1 (0.61) TSHRLTA4HNR5A1NPC1RAB9A
SCHEMBL3045830 0.94 NR5A1 (0.61) TSHRLTA4HNR5A1NPC1RAB9A
SCHEMBL9713418 0.94 NR5A1 (0.61) TSHRLTA4HNR5A1NPC1RAB9A
SCHEMBL3053786 0.94 NR5A1 (0.61) TSHRLTA4HNR5A1NPC1RAB9A
SCHEMBL3046736 0.94 NR5A1 (0.61) TSHRLTA4HNR5A1NPC1RAB9A
SCHEMBL14608689 0.94 NR5A1 (0.61) TSHRLTA4HNR5A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12637421-B2 Anthraquinone compound, liquid crystal composition containing said compound, and dimming element NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2026-05-26 US disclosed
US-20250304531-A1 ANTHRAQUINONE COMPOUND, LIQUID CRYSTAL COMPOSITION CONTAINING SAID COMPOUND, AND DIMMING ELEMENT NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2025-10-02 US disclosed
EP-4442679-A1 ANTHRAQUINONE COMPOUND, LIQUID CRYSTAL COMPOSITION CONTAINING SAID COMPOUND, AND DIMMING ELEMENT Nippon Kayaku Kabushiki Kaisha (JP) 2024-10-09 EP disclosed
CN-118251378-A Anthraquinone compound, liquid crystal composition containing same, and light adjusting element 日本化药株式会社 2024-06-25 CN disclosed
US-10421779-B2 Carbazole compound having anti-virus activity KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2019-09-24 US disclosed
US-20180057527-A1 CARBAZOLE COMPOUND HAVING ANTI-VIRUS ACTIVITY KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2018-03-01 US disclosed
US-9663482-B2 Substituted piperazinyl acetohydrazide procaspase-activating compounds THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2017-05-30 US disclosed
US-20160176833-A1 ENZYME-ACTIVATING COMPOUNDS AND COMPOSITIONS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2016-06-23 US disclosed
US-9249116-B2 Enzyme-activating compounds and compositions THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2016-02-02 US disclosed
US-20150231132-A1 PROCASPASE-ACTIVATING COMPOUNDS AND METHODS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 2015-08-20 US disclosed
US-7361677-B2 Polycyclic sulphamate compounds suitable for use as inhibitors of aromatase and/or sulphatase STERIX, LTD. (GB) 2008-04-22 US disclosed
US-20070190523-A1 Method and compositions for identifying anti-hiv therapeutic compounds GILEAD SCIENCES, INC. 2007-08-16 US disclosed
US-20070010489-A1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds GILEAD SCIENCES, INC. 2007-01-11 US disclosed
WO-2006085974-A2 AMPHIPHILIC DENDRITIC DIPEPTIDES & THEIR SELF-ASSEMBLY INTO HELICAL PORES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2006-08-17 WO disclosed
US-7087644-B1 Derivatives of dicarboxylic acid having pharmaceutical properties BAYER AKTIENGESELLSCHAFT (DE) 2006-08-08 US disclosed
US-20060094769-A1 Novel aminodicarboxylic acid derivatives having pharmaceutical properties BAYER AKTIENGESELLSCHAFT (DE) 2006-05-04 US disclosed
US-20060088499-A1 Amphiphilic dendritic dipeptides & their self-assembly into helical pores THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2006-04-27 US disclosed
US-4400293-A Liquid crystalline cyclohexylphenyl derivatives MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1983-08-23 US disclosed
US-4308273-A 1,6-Naphthyridine derivatives, and antidinic and cerebral circulation improver containing such derivatives NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1981-12-29 US disclosed
US-4178383-A Fungicidally active oxime-ethers of isonitrosocyanoacetamides BAYER AKTIENGESELLSCHAFT (DE) 1979-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180057527-A1 CARBAZOLE COMPOUND HAVING ANTI-VIRUS ACTIVITY ZC3HAV1, ZC3HAV1L, GTF3C3 TSHR 4712/4885LTA4H 3545/4885NR5A1 563/4885
US-20060088499-A1 Amphiphilic dendritic dipeptides & their self-assembly into helical pores DNPEP, VIP, APLNR TSHR 3821/4885LTA4H 2792/4885NR5A1 3991/4885
US-12637421-B2 Anthraquinone compound, liquid crystal composition containing said compound, and dimming element ACIN1, ANTXR2, CXCR1 TSHR 3212/4885LTA4H 1836/4885NR5A1 1146/4885
US-20150231132-A1 PROCASPASE-ACTIVATING COMPOUNDS AND METHODS CASP3, CASP5, CASP6 TSHR 4827/4885LTA4H 1039/4885NR5A1 4721/4885
US-20060094769-A1 Novel aminodicarboxylic acid derivatives having pharmaceutical properties DDC, AADAT, PTGIS TSHR 4504/4885LTA4H 96/4885NR5A1 1900/4885
US-20250304531-A1 ANTHRAQUINONE COMPOUND, LIQUID CRYSTAL COMPOSITION CONTAINING SAID COMPOUND, AND DIMMING ELEMENT ACMSD, CYBA, BCKDK TSHR 4463/4885LTA4H 1788/4885NR5A1 456/4885
US-20160176833-A1 ENZYME-ACTIVATING COMPOUNDS AND COMPOSITIONS RNASE1, CASP3, CASP5 TSHR 4811/4885LTA4H 441/4885NR5A1 3771/4885
US-20070010489-A1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds PPA1, PNP, PPME1 TSHR 4782/4885LTA4H 1533/4885NR5A1 4033/4885
US-10421779-B2 Carbazole compound having anti-virus activity ZC3HAV1, ZC3HAV1L, GTF3C3 TSHR 4712/4885LTA4H 3545/4885NR5A1 563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.